Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baer, P. C.
Right arrow Articles by Geiger, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baer, P. C.
Right arrow Articles by Geiger, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 184-190
© 2000 European Renal Association-European Dialysis and Transplant Association

Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro

Patrick C. Baer1, Stefan Gauer1, Ingeborg A. Hauser1, Jürgen E. Scherberich2 and Helmut Geiger1

1 Division of Nephrology, Department of Internal Medicine IV, J. W. Goethe-University, Frankfurt/M., and 2 Division of Nephrology, Department of Medicine II, Hospital München Harlaching, Germany

Correspondence and offprint requests to: Patrick C. Baer, Johann Wolfgang Goethe University, Department of Internal Medicine IV, Division of Nephrology, Theodor Stern-Kai 7, D-60590 Frankfurt/M., Germany.

Background.Mycophenolic acid has been shown to be effective for the prevention and treatment of renal allograft rejection. Rejection episodes were found to be associated with an infiltration of lymphocytes and macrophages/monocytes into the diseased kidney. Expression of RANTES, HLA-DR and ICAM-1 may be important for the pathogenesis of this leukocyte infiltration. Therefore the aim of this study was to evaluate the effect of the antiproliferative and immunosuppressive agent mycophenolic acid (MPA) on cell growth and cytokine-induced expression of RANTES, HLA-DR and ICAM-1 of highly purified proximal (PTC) and distal tubular cells (DTC) from human kidney.

Methods.Human PTC and DTC were cultured in the presence of different concentrations of MPA (0.25–50 µM) or MPA plus guanosine (100 µM). Total cell number (DNA content) was determined after 4 days of cell culture by a non-radioactive fluorescence assay. Cells were stimulated by a combination of cytokines (IL1ß+{gamma}IFN+TNF{alpha}=cytomix) or cytomix plus MPA. Secretion of RANTES protein was evaluated with an enzyme-linked-immunosorbent assay. Cell surface expression of HLA-DR and ICAM-1 was assessed by flow cytometric analysis.

Results.MPA inhibited cell growth of PTC and DTC in a dose-dependent manner. This effect was totally abolished by the addition of guanosine. Cytokine-induced RANTES expression was synergistically increased in the presence of MPA, an effect that was partially prevented by the addition of guanosine. Cytokine stimulation resulted in de novo expression of HLA-DR and a marked increase of ICAM-1 expression, which was partially inhibited by dexamethasone. Addition of MPA did not influence this stimulated expression.

Conclusions.We demonstrate that MPA has an effect on cell growth and chemokine release of tubular epithelial cells, and that these effects are dependent on the inhibition of cellular guanosine production. The clinical consequences of this possible pro-inflammatory effect of MPA on RANTES release may be abolished by a concomitant treatment with steroids.

Keywords: distal tubule; epithelial cells; human; mycophenolic acid; proliferation; proximal tubule


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. Herrera, A. Ferrebuz, E. G. MacGregor, and B. Rodriguez-Iturbe
Mycophenolate Mofetil Treatment Improves Hypertension in Patients with Psoriasis and Rheumatoid Arthritis
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S218 - S225.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
L. Ding, M. Zhao, W. Zou, Y. Liu, and H. Wang
Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study
Lupus, February 1, 2004; 13(2): 113 - 118.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
P. C. Baer, B. Wegner, and H. Geiger
Effects of mycophenolic acid on IL-6 expression of human renal proximal and distal tubular cells in vitro
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 47 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Nieto, E. Escudero, E. Navarro, M. Yanez-Mo, A. Martin, G. Perez de Lema, F. Sanchez-Madrid, and F. Mampaso
Effects of Mycophenolate Mofetil in Mercury-Induced Autoimmune Nephritis
J. Am. Soc. Nephrol., April 1, 2002; 13(4): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Badid, A. Desmouliere, and M. Laville
Mycophenolate mofetil: implications for the treatment of glomerular disease
Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1752 - 1756.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.